Sopharma AD-Sofia (XBUL:SFA) 3-Year FCF Growth Rate

: 0.00% (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

Sopharma AD-Sofia's Free Cash Flow per Share for the three months ended in Dec. 2023 was лв0.56.

During the past 12 months, Sopharma AD-Sofia's average Free Cash Flow per Share Growth Rate was -98.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Sopharma AD-Sofia was 12.00% per year. The lowest was -36.60% per year. And the median was -12.35% per year.

Competitive Comparison

For the Medical Distribution subindustry, Sopharma AD-Sofia's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sopharma AD-Sofia 3-Year FCF Growth Rate Distribution

For the Medical Distribution industry and Healthcare sector, Sopharma AD-Sofia's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Sopharma AD-Sofia's 3-Year FCF Growth Rate falls into.

Sopharma AD-Sofia 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

Sopharma AD-Sofia (XBUL:SFA) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.

Sopharma AD-Sofia 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Sopharma AD-Sofia's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Sopharma AD-Sofia (XBUL:SFA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma AD-Sofia (XBUL:SFA) » Definitions » 3-Year FCF Growth Rate

Comparable Companies

Traded in Other Exchanges

SPH:Poland

Address

5 Lachezar Stanchev Street, Sopharma Business Towers, Building A, Floor 11, Sofia, BGR, 1756

Website

https://www.sopharmagroup.com

Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are organized based on the production of finished products which include Tablet dosage forms, Ampoule dosage forms, Medical products, Other forms, and Other revenue. Geographically company operates in Bulgaria and internationally.

Sopharma AD-Sofia (XBUL:SFA) Headlines

No Headlines